Valuation : LivaNova PLC

Market Cap 4.43B 3.81B 3.58B 3.26B 6.15B 423B 6.17B 42.42B 16.55B 213B 16.61B 16.25B 708B P/E 2026 *
20.1x
P/E 2027 * 24.2x
Enterprise Value 4.5B 3.88B 3.64B 3.32B 6.25B 430B 6.27B 43.14B 16.83B 217B 16.9B 16.53B 720B EV / Sales 2026 *
2.96x
EV / Sales 2027 * 2.66x
Free-Float
98.6%
Yield 2026 *
-
Yield 2027 * -
1 day+0.36%
1 week+2.01%
Current month+0.22%
1 month-0.90%
3 months+8.83%
6 months+14.30%
Current year+30.54%
1 week 77.63
Extreme 77.63
80.76
1 month 74.67
Extreme 74.6701
85.76
Current year 56.44
Extreme 56.44
85.76
1 year 48.82
Extreme 48.82
85.76
3 years 32.48
Extreme 32.48
85.76
5 years 32.48
Extreme 32.48
93.89
10 years 32.48
Extreme 32.48
131.54
Manager TitleAgeSince
Chief Executive Officer 53 29/02/2024
Director of Finance/CFO 56 30/10/2020
Investor Relations Contact - 31/07/2022
Director TitleAgeSince
Director/Board Member 69 18/10/2015
Chairman 74 08/06/2021
Director/Board Member 62 17/06/2019
Date Insider Type Main position Quantity % Market Cap.
11/08/26 Fiscal year

Executive/Senior Manager

38,076 0.0693%
10/06/26 Other

Director

0 0%
26/05/26 Sell

Director

-1,800 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
+0.36%+2.01%+42.49%+43.12% 4.43B
+0.79%-3.58%-15.22%+7.72% 195B
+1.40%-2.27%-1.70%+10.84% 117B
+0.25%+1.25%+10.43%+80.01% 61.45B
+0.74%-1.29%-1.79%-32.39% 51.62B
+0.80%-1.18%+27.69%+52.27% 51.03B
+1.71%-1.65%+20.55%-12.18% 34.27B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+36.66%-17.51% 23.75B
-0.91%-3.06%-6.22%+14.03% 23.41B
Average +0.45%-1.01%+12.54%+16.21% 59.23B
Weighted average by Cap. +0.76%-1.92%+0.74%+14.90%

Financials

2026 *2027 *
Net sales 1.52B 1.31B 1.23B 1.12B 2.11B 145B 2.12B 14.59B 5.69B 73.43B 5.71B 5.59B 243B 1.63B 1.4B 1.32B 1.2B 2.26B 156B 2.27B 15.63B 6.1B 78.65B 6.12B 5.99B 261B
Net income 226M 195M 183M 167M 314M 21.62B 315M 2.17B 846M 10.92B 849M 831M 36.19B 187M 161M 151M 138M 260M 17.86B 261M 1.79B 699M 9.02B 702M 687M 29.9B
Net Debt 75M 64.63M 60.59M 55.31M 104M 7.17B 105M 719M 280M 3.62B 282M 275M 12B -85M -73.24M -68.67M -62.69M -118M -8.12B -118M -815M -318M -4.1B -319M -312M -13.6B
Logo LivaNova PLC
LivaNova PLC is a medical technology company. The Company designs, develops, manufactures, markets and sells products and therapies. Its segments include Cardiopulmonary, and Neuromodulation. Its Cardiopulmonary segment is engaged in the design, development, manufacture, marketing, and sale of cardiopulmonary products, including heart-lung machines (HLM), oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories. Its Neuromodulation segment is engaged in the design, development, manufacture, marketing, and sale of devices that deliver neuromodulation therapy for treating drug-resistant epilepsy (DRE) and difficult-to-treat depression (DTD). Its principal Neuromodulation product, the VNS Therapy System, consists of an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals.
Employees
3,300
Date Price Change Volume
28/08/26 US$80.32 +0.36% 465,952
27/08/26 US$80.03 +0.08% 611,275
26/08/26 US$79.97 +0.71% 733,430
25/08/26 US$79.41 +1.47% 562,919
24/08/26 US$78.26 -0.61% 823,214
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
80.32USD
Average target price
88.80USD
Spread / Average Target
+10.56%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LIVN Stock